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Mutations in X-linked ephrin-B1 in humans cause craniofrontonasal syndrome (CFNS), a disease that affects female
patients more severely than males. Sorting of ephrin-B1–positive and –negative cells following X-inactivation has been
observed in ephrin-B1
þ/  mice; however, the mechanisms by which mosaic ephrin-B1 expression leads to cell sorting
and phenotypic defects remain unknown. Here we show that ephrin-B1
þ/  mice exhibit calvarial defects, a phenotype
autonomous to neural crest cells that correlates with cell sorting. We have traced the causes of calvarial defects to
impaired differentiation of osteogenic precursors. We show that gap junction communication (GJC) is inhibited at
ectopic ephrin boundaries and that ephrin-B1 interacts with connexin43 and regulates its distribution. Moreover, we
provide genetic evidence that GJC is implicated in the calvarial defects observed in ephrin-B1
þ/  embryos. Our results
uncover a novel role for Eph/ephrins in regulating GJC in vivo and suggest that the pleiotropic defects seen in CFNS
patients are due to improper regulation of GJC in affected tissues.
Citation: Davy A, Bush JO, Soriano P (2006) Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS Biol
4(10): e315. DOI: 10.1371/journal.pbio.0040315
Introduction
Physical segregation, or sorting, of different cell popula-
tions during development is essential for the proper spatial
organization of the animal body. Eph receptor tyrosine
kinases and ephrins regulate many developmental processes
[1–3], and play an important role in tissue patterning by
restricting cell intermingling and establishing developmental
boundaries [4–6].
A dramatic example of the role of Eph and ephrins in cell
sorting, as well as the importance of proper cell sorting
during development, was recently provided by the analysis of
the phenotypes exhibited by ephrin-B1 heterozygous female
mice [7,8] and by the identiﬁcation of mutations in the ephrin-
B1 gene in human craniofrontonasal syndrome (CFNS)
patients [9,10]. As a result of random X-inactivation, X-linked
ephrin-B1 expression is mosaic in ephrin-B1
þ/  mice and
ephrin-B1–positive and ephrin-B1–negative cells segregate
from one another. This correlates with a polydactyly
phenotype that is never observed in ephrin-B1 null animals
[7,8]. Similarly, CFNS is an X-linked developmental disorder
characterized by a number of craniofacial defects including
abnormal development of the cranial and nasal bones, and
craniosynostosis (premature fusion of the coronal sutures), as
well as extracranial anomalies (including polydactyly and
syndactyly), affecting mainly female patients [11].
Despite years of intensive studies, the molecular mecha-
nisms by which Eph receptors and ephrins inﬂuence cell
sorting are still poorly understood. Eph receptors and
ephrins function as an unusual receptor/ligand pair in which
both receptor and ligand are capable of activating a signaling
cascade. One prominent outcome of Eph/ephrin interactions
is the regulation of cell–substrate adhesion and reorganiza-
tion of the actin cytoskeleton. It has also been reported that
Eph receptors and ephrins regulate gap junction communi-
cation (GJC) [6]. Indeed, studies in zebraﬁsh have shown that
expression of Eph receptors and ephrins in animal cap cells
was sufﬁcient to block GJC at the boundary between both cell
populations. Gap junctions are intercellular membrane
channels that mediate cell coupling by allowing the passage
of small molecules directly from cell to cell. During vertebrate
development, regions of GJC coincide with developmental
compartments [12,13]. For instance, GJC is reduced at inter-
rhombomeric boundaries, as compared to GJC in the
rhombomeres themselves. GJC is involved in various devel-
opmental processes and mutations in connexins, the struc-
tural proteins forming gap junctional pores, have been linked
to a number of human diseases [14]. Notably, GJC plays an
important role in skeletal development [15] and mutations in
connexin43 (Cx43) lead to cranial and skeletal defects both in
humans and mice [16,17].
In this report, we have investigated the underlying cause of
the phenotypes observed in ephrin-B1 heterozygous mice. We
show that cell sorting in ephrin-B1
þ/  females induces calvarial
defects due to the impaired differentiation of neural crest
cells (NCCs). We provide evidence that GJC is inhibited at
ectopic ephrin boundaries and that ephrin-B1 physically
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PLoS BIOLOGYinteracts with Cx43 and inﬂuences its distribution. In
addition, we report that overexpression of Cx43 partially
rescues the calvarial defects observed in ephrin-B1 hetero-
zygotes. Finally, we show that regulation of GJC correlates
with cell sorting in response to Eph/ephrin interaction. From
these results we conclude that mosaic loss of ephrin-B1 exerts a
dominant effect during development involving perturbation
of GJC at ectopic Eph/ephrin boundaries and leading to
defective tissue differentiation. These observations extend
our understanding of the mechanisms underlying CFNS in
humans and of the role of Eph receptors and ephrins in vivo.
Results
Craniofacial Phenotypes in ephrin-B1 Heterozygous
Females
We and others have shown previously that ephrin-B1
þ/ 
females exhibit a polydactyly phenotype that is never seen in
ephrin-B1
Y/  males or ephrin-B1
 /  females [7,8]. Because CFNS
human female patients exhibit numerous craniofacial defects,
we undertook a closer analysis of ephrin-B1 heterozygous
female mice that revealed several defects in NCC-derived
tissues that were not seen in hemizygous males or homozygous
females. At P1, ephrin-B1
þ/  heterozygous females (n ¼ 17)
presented an opening (foramen) between the frontal bones
and jagged bone fronts (Figure 1Ab), indicative of abnormal
development of the frontal bones. (The parietal bone was
affected at lower penetrance). Ephrin-B1
 /  homozygous null
females (n ¼ 3) and ephrin-B1
Y/  hemizygous males (n ¼ 13)
exhibited a normal development of these bones (Figure 1Aa
and unpublished data). The frontal bone phenotype was
recapitulated in heterozygous females carrying a deletion of
ephrin-B1 speciﬁcally in NCCs (n ¼ 3) (Figure 1Ac), consistent
with the NCC origin of frontal bones [18]. Ephrin-B1
þ/ females
also exhibited abnormal alignment of the vibrissae buds which
was recapitulated by conditional deletion of ephrin-B1 in NCCs
(ephrin-B1
þ/lox;Wnt1Creþ), indicating that the defect is autono-
mous to this lineage (Figure S1).
It has been proposed by others that the mild manifestations
of CFNS in male carriers might be due to compensatory
mechanisms by other ephrins [10]. To test this hypothesis, we
asked whether further alteration in the dosage of ephrin
signaling would lead to calvarial phenotypes in ephrin-B1 null
mutants. We chose to focus on ephrin-B2 since loss of this gene
has been shown previously to affect migration of a sub-
population of cranial NCCs [19] and ephrin-B2 is expressed in
the craniofacial area (Figure 2) We generated a mouse line
harboring a null mutation in the ephrin-B2 gene by placing a
cDNA coding for a fusion protein between histone 2B (H2B)
and the green ﬂuorescent protein (GFP) under the control of
the ephrin-B2 promoter (A. Davy, P. Soriano, unpublished
data). ephrin-B2 and ephrin-B1 heterozygous animals were
mated to generate ephrin-B1/ephrin-B2 double heterozygous
animals. Skeleton preparations showed that removal of one
copy of ephrin-B2 in an ephrin-B1
þ/  background worsened the
calvarial phenotype (Figure 1B). Indeed, in addition to a
largergapbetweenthefrontalbones(FigureS2A),ephrin-B1
þ/ /
ephrin-B2
þ/GFP embryos (n ¼ 5) exhibited a coronal suture
defect that was not observed in ephrin-B1 single mutants,
malesorfemales.Bonefrontsatcoronalsuturesinephrin-B1
þ/ /
ephrin-B2
þ/GFP embryos did not overlap, and ectopic bone was
frequently observed in the suture mesenchyme (Figure 1Bc).
Examination of skeleton preparations from E15.5 embryos
indicated that although bone formation in ephrin-B1
þ/ /ephrin-
B2
þ/GFP embryos proceeded comparably to ephrin-B1
þ/ 
embryos, bone fronts seemed unable to extend toward each
other at the coronal suture (Figure 1Bf). Importantly, ephrin-
B1
Y/ /ephrin-B2
þ/GFP double hemi/heterozygous males (n ¼ 3)
exhibited normal calvarial development (Figure 1Bd and
unpublished data). Altogether, these results show that mosaic
loss of ephrin-B1 exerts a dominant effect on the development
of calvarial bones. Removal of one copy of ephrin-B2 in an
ephrin-B1
þ/  background was sufﬁcient to uncover additional
defects at the coronal suture; however, it did not lead to
calvarial phenotypes in ephrin-B1 null embryos, suggesting
that the lack of calvarial phenotype in these embryos is not
due to compensation by ephrin-B2.
Defects in NCC-Derived Structures Correlate with Cell-
Sorting in ephrin-B1
þ/  Embryos
To better understand the basis for the calvarial phenotypes
observed in ephrin-B1 heterozygotes, we analyzed the expres-
sion pattern of ephrin-B1 and ephrin-B2, and their cognate
receptors EphB2 and EphB3 at various stages of development.
These receptors have been implicated both in the polydactyly
phenotype and in the formation of the palate [20], a NCC-
derived structure that also requires ephrin-B1. At E14.5,
expression of ephrin-B1, EphB2, and EphB3 can be detected
in the developing frontal bones (Figure 2A). Ephrin-B1 and
EphB3 are expressed throughout the bone whereas EphB2
expression appears to be restricted ventrally. Interestingly,
ephrin-B1 is also strongly expressed in the meningeal layer
which derives from neural crest cells [18]. At E12.5, a stage
that corresponds to the early stages of calvarial bone
differentiation, ephrin-B1 is expressed throughout the head
mesenchyme as well as in the vibrissae buds in wild-type
embryos (Figure 2Ba and Figure S1). In ephrin-B1
þ/  embryos,
expression of ephrin-B1 is patchy throughout the craniofacial
mesenchyme and in the telencephalon, and highlights the
defective formation of vibrissae buds (Figure 2Bb). Both
ephrin-B2 and EphB2 exhibit expression patterns that are
similar to ephrin-B1 (Figure 2Bc and 2Be). Expression of
ephrin-B2, however, is unchanged in ephrin-B1
þ/  (Figure 2Bd)
whereas EphB2 expression appears patchy (Figure 2Bf). It has
been reported previously that patchy expression of ephrin-B1
in ephrin-B1
þ/  limb buds reﬂects sorting between ephrin-B1–
positive and –negative cell populations that are generated in
the ephrin-B1 heterozygous females via random X-inactivation
and that this abnormal expression of ephrin-B1 in the limb
bud correlates with a polydactyly phenotype that is observed
in ephrin-B1
þ/  females [7,8]. Our data demonstrate that the
calvarial phenotypes observed in ephrin-B1 heterozygous
females correlate with an abnormal expression of ephrin-B1
and EphB2 in the presumptive frontal bone, likely due to cell
sorting between ephrin-B1–positive and ephrin-B1–negative
cells in the craniofacial mesenchyme.
The Frontal Bone Defect Is Caused by Abnormal
Osteogenic Differentiation
To uncover the nature of the dominant effect of mosaic
loss of ephrin-B1, we reasoned that understanding why sorting-
out between ephrin-B1–positive and ephrin-B1–negative cells
has such consequences for the development of this tissue
would shed light on the dominant function of ephrin-B1.
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Inhibition of GJC at ephrin BoundariesNCCs are the source of the frontal bone osteoprogenitor
population, and both ephrin-B1 and ephrin-B2 control migra-
tion of these cells, raising the possibility that improper
migration of NCC progenitors could be responsible for the
frontal bone phenotype. Using a combination of Wnt1Cre/
R26R alleles to speciﬁcally label NCCs, we found no differ-
ence in the size of the progenitor pool between ephrin-B1
heterozygous females and wild-type animals (Figure 3A),
indicating that defective migration is not the likely cause for
the frontal bone phenotype. In addition, no proliferation or
cell survival defects were detected on sections of mutant
frontal bones (unpublished data).
To test whether the defects in calvarial bone development
in ephrin-B1
þ/  e m b r y o sc o r r e l a t e dw i t hp e r t u r b a t i o no f
osteoblastic differentiation, we used alkaline phosphatase
(AP) activity as a marker of early osteoblastic differentiation.
At E16.5, AP staining of frontal bones showed delayed
differentiation in ephrin-B1
þ/ /ephrin-B2
þ/GFP and ephrin-B1
þ/ 
(Figure S2B and unpublished data). At E12.5, similar levels of
AP activity could be detected in wild-type, ephrin-B1
Y/ , and
ephrin-B1
þ/  embryos (Figure 3B), indicating that defective
bone growth was not due to delayed onset of differentiation in
heterozygous mutants. However, unlike wild-type and ephrin-
B1
Y/  embryos which showed continuous AP activity, AP
staining of the presumptive frontal bone appeared irregular
in ephrin-B1 heterozygous embryos( F i g u r e3 B c ) .T h e s e
observations indicate that the calvarial defects observed in
ephrin-B1
þ/  mutants are not due to abnormal migration or
survival of NCCs, but instead might be due to a defective
differentiation of the presumptive osteogenic mesenchyme.
Figure 1. ephrin-B1
þ/  Embryos Exhibit Defects in NCC Derivatives
(A) Skeleton preparations of whole heads from E18.5 mutant embryos (a–c). Bones are stained with Alizarin Red while cartilage is stained with Alcian
Blue. An opening (foramen) between frontal bones is observed in ephrin-B1
þ/  heterozygous females (b) but not in ephrin-B1
 /  homozygous females
(a). Mutant embryos in which ephrin-B1 is specifically deleted in NCC also exhibit defects of the frontal bones (c). Arrowheads show the bone front of
the frontal bones. Schematic drawings of the frontal bones (d–f).
(B) Skeleton preparations of whole heads from E18.5 embryos (a–c) or E15.5 embryos (d–f) show that ephrin-B1
þ/ /ephrin-B2
þ/GFP embryos present an
additional coronal suture defect (c) and (f) as compared to ephrin-B1
þ/  single heterozygous females (b) and (e). At E18.5, bone fronts never overlap at
coronal sutures of ephrin-B1
þ/ /ephrin-B2
þ/GFP embryos, and ectopic bone forms in the suture mesenchyme (arrow in [c]). At E15.5, parietal and frontal
bone fronts forming the coronal suture (arrow) of ephrin-B1
þ/ /ephrin-B2
þ/GFP embryos (f) are further apart than in control littermates (d) and (e). Coronal
suture and frontal bones are normal in single ephrin-B2
þ/GFP heterozygous mutants (a) and in ephrin-B1
Y/ /ephrin-B2
þ/GFP males (d).
fb, frontal bone; pb, parietal bone.
DOI: 10.1371/journal.pbio.0040315.g001
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Inhibition of GJC at ephrin BoundariesTo conﬁrm the differentiation defects observed in ephrin-
B1 heterozygotes, we isolated presumptive osteogenic mes-
enchymal cells from E14.5 wild-type and ephrin-B1
þ/ embryos,
and evaluated their ability to differentiate in vitro. Using AP
activity as a marker for osteogenic differentiation, we
observed that cells isolated from ephrin-B1
þ/  embryos were
consistently less prone to differentiate in vitro (Figure 3C),
indicating that these defects are autonomous to the osteo-
progenitor cells. In these primary cultures, expression of
ephrin-B1 was detected in a punctate pattern in both AP-
positive as well as AP-negative cells (Figure S3A), indicating
that expression of ephrin-B1 and AP do not strictly correlate,
and suggesting that ephrin-B1 does not regulate AP activity
directly.
Defective Osteogenic Differentiation in ephrin-B1
þ/ 
Embryos Correlates with Abnormal Cx43 Distribution
Using this in vitro system, we tested a number of markers
that have been shown to regulate osteogenic differentiation,
including N-cadherin and Cx43 expression, as well as
activation of MAPK. Among these, only Cx43 distribution
showed prevalent changes between cultures from wild-type
and ephrin-B1 heterozygous embryos (Figure 4A and unpub-
lished data). Cx43 is a structural protein that forms gap
junctional pores (connexons). Whereas cytoplasmic Cx43
shows a diffuse staining by immunoﬂuorescence, cell surface
connexons appear as bright dots because they aggregate to
form functional gap junctional plaques at cell–cell interfaces.
In cultures of mesenchymal cells isolated from wild-type
Figure 2. Expression of ephrin-B1 and EphB2 Is Abnormal in ephrin-B1
þ/  Embryos
(A) In situ hybridization on frontal sections of E14.5 wild-type embryo using probes for ephrin-B1 (a), EphB2 (b), or EphB3 (c). Ephrin-B1 is expressed
throughout the developing frontal bone (marked by dotted lines) as well as in the meningeal layer (arrowheads). Expression of EphB2 is restricted
ventrally (arrowheads) whereas EphB3 is expressed throughout the developing frontal bone.
(B) In situ hybridization of wild-type (a), (c), and (e) or ephrin-B1
þ/  embryos (b), (d), and (f) using a probe for ephrin-B1 (a) and (b), ephrin-B2 (c) and (d)
and EphB2 (e) and (f). Both ephrin-B1 and EphB2 show sorting in the telencephalon and the craniofacial mesenchyme of ephrin-B1
þ/  embryos
(arrowheads) while expression of ephrin-B2 is unaffected.
DOI: 10.1371/journal.pbio.0040315.g002
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Inhibition of GJC at ephrin Boundariesembryos, the differentiating cells expressed a high level of
Cx43, and gap junctional plaques were readily visible between
these cells (Figure 4Aa and 4Ab). On the contrary, in cultures
of mesenchymal cells isolated from ephrin-B1 heterozygous
embryos, the distribution of Cx43 was altered and gap
junctional plaques were not detected (Figure 4Ac and 4Ad).
Western blot analysis indicated that the overall level of Cx43
was unchanged in primary cultures isolated from ephrin-B1
heterozygous embryos, indicating that the distribution but
not the expression of Cx43 was altered in primary cultures
from ephrin-B1
þ/  embryos (Figure S3B).
We next tested whether distribution of Cx43 was also
altered in ephrin-B1 mosaic embryos. For this purpose, we co-
stained parafﬁn sections from control and heterozygous
mutant E12.5 embryos with AP and Cx43. However, even
though AP staining of the frontal bone was very irregular in
the ephrin-B1
þ/  embryo, compared to the control frontal
bone (Figure S3Ca and S3Cc), we were unable to detect
signiﬁcant differences in Cx43 staining on these sections
(Figure S3Cb and S3Cd). Since ephrin-B1 null embryos do not
show calvarial phenotype or abnormal osteogenic differ-
entiation, we reasoned that ephrin-B1 itself might not be
required for proper localization of Cx43, but rather that
abnormal distribution of Cx43 might be seen only at the
boundary between ephrin-B1–positive and –negative cells in
the mosaic embryos. To be able to detect boundaries between
ephrin-B1–positive and ephrin-B1–negative cells, we gener-
ated chimeric embryos by injecting ephrin-B1 null embryonic
stem (ES) cells in wild-type ROSA26 blastocysts which express
b-galactosidase constitutively. Parafﬁn sections of X-gal–
stained E11.5 chimeric embryos were processed for immuno-
ﬂuorescence using the Cx43 antibody. Gap junctional Cx43
was readily detected between wild-type cells and between
ephrin-B1 null cells (Figure 4B). However, gap junctional Cx43
was almost never observed between ephrin-B1–positive and –
negative cells. We concluded that the number of junctional
pores is diminished at ephrin-B1–positive/ephrin-B1–nega-
tive boundaries in vivo.
Ephrin-B1 Associates with Cx43 and Regulates GJC
Compagni et al. have shown that the levels of EphB2
receptor are up-regulated in ephrin-B1–negative domains in
ephrin-B1
þ/  embryos, thus creating ectopic Eph/ephrin
boundaries [7]. We therefore reasoned that decreased junc-
tional Cx43 at ephrin-B1–positive/ephrin-B1–negative boun-
daries in vivo could in fact indicate an inhibition of GJC by
Eph/ephrin signaling. To test whether Eph/ephrin signaling
could regulate GJC, we used calcein-AM as a marker of GJC in
vitro. We found that interaction between ephrin-B1 and Eph-
B2 resulted in inhibition of GJC in vitro (Figure 5). NIH 3T3
cells expressing ephrin-B1 showed reduced transfer of
Figure 3. Calvarial Foramen Correlates with Impaired Osteogenic Differentiation
(A) E11.5 embryos carrying the R26R and Wnt1-Cre alleles were processed for X-gal staining to label NCCs. No difference in the osteogenic precursor
population (arrow) was detected in ephrin-B1
þ/  females (b) as compared to wild type (a).
(B) E12.5 wild-type (a), ephrin-B1
Y/ (b), and ephrin-B1
þ/ (c) embryos were stained for AP activity. The onset of osteogenic differentiation does not seem
affected in the mutant embryos, but AP staining pattern is irregular in the heterozygote mutant as compared to wild-type and homozygote mutant,
with areas devoid of staining (arrows).
(C) Primary mesenchymal cells were isolated from presumptive calvaria of E14.5 ephrin-B1
Y/  hemizygous male (a) or ephrin-B1
þ/  heterozygous female
(b) and plated at high density. AP activity was evaluated after 3 d in culture. Digital quantification of AP activity (c).
DOI: 10.1371/journal.pbio.0040315.g003
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Inhibition of GJC at ephrin Boundariescalcein-AM when plated on cells expressing low levels of Eph-
B2 (Figure 5Ab), as compared to control cells (Figure 5Aa).
More dramatically, plating of ephrin-B1–expressing cells over
cells expressing high levels of Eph-B2 resulted in a complete
inhibition of GJC (Figure 5Ac). Similar results were obtained
using primary NCCs that express both ephrin-B1 and Eph-B2
at low levels. Although primary NCCs were able to establish
strong GJC with control ﬁbroblasts (Figure 5Ba and 5Bd),
plating onto ﬁbroblasts expressing ephrin-B1 markedly
decreased dye transfer, even though the majority of the cells
were able to spread normally (Figure 5Bb and 5Be). The fact
that some cells spread normally, but were unable to transfer
the dye (Figure 5Bf), indicates that inhibition of GJC is not
due to cell repulsion. Plating of primary NCCs onto
ﬁbroblasts expressing Eph-B2 resulted in a moderate reduc-
tion in GJC (Figure 5Bc). We quantiﬁed GJC by two means:
Figure 4. Decreased Osteogenic Differentiation Correlates with Abnormal Distribution of Cx43
(A) Primary mesenchymal cells isolated from presumptive calvaria of wild-type (a) and (b) or ephrin-B1
þ/ embryos (c) and (d) were stained for AP activity
(a) and (c) and subsequently processed for Cx43 immunofluorescence (b) and (d). Junctional Cx43 evidenced by bright dots is readily detected in
cultures from wild-type embryos (WT), but not in cultures from ephrin-B1
þ/  embryos.
(B) Detection of Cx43 by immunofluorescence in limb bud sections of an X-gal–stained chimeric embryo obtained by injecting ephrin-B1 null cells into a
ROSA26-bgal blastocyst. Gap junctional Cx43 appears as bright dots (a). The boundary between wild-type cells (dark cells in [c]) and ephrin-B1 null cells
(white cells in [c]) is indicated by red arrows. A schematic representation of the results is shown (b). Grey cells are wild type and white cells are ephrin-B1
null. Cx43 dots are in red, whereas yellow in (b) marks the only Cx43 dot that might be between a wild-type and a null cell. Quantification of Cx43 dots
in multiple sections show a reduction in the number of Cx43 dots between wild-type and null cells (WT-KO) (d).
DOI: 10.1371/journal.pbio.0040315.g004
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Inhibition of GJC at ephrin Boundariesﬁrst, we evaluated the number of donor cells that had spread
and were able to transfer the dye (Figure 5Ca). Second, we
counted the number of receiving cells for each donor cell that
had spread and transferred the dye (Figure 5Cb). Both
measurements indicate that GJC is diminished when primary
NCCs are plated on ephrin-B1– (and to a lower extent
EphB2–) expressing cells. These results demonstrate that
interaction between EphB2 and ephrin-B1 impairs establish-
ment of GJC.
To better understand the molecular mechanisms by which
Eph/ephrins might impinge on Cx43 distribution and
regulate GJC, we analyzed the distribution of both ephrin-
B1 and Cx43 in cell culture. Co-immunoﬂuorescence studies
showed that Cx43 and ephrin-B1 partially co-localize in
primary mesenchymal cells (Figure 6A). We then analyzed the
effect of Eph/ephrin engagement on Cx43 distribution in cell
lines in which ephrin-B1 was transiently transfected. Ex-
pression of ephrin-B1 and Cx43 was partially overlapping in
untreated NIH 3T3 cells, especially at interfaces between cells
expressing ephrin-B1, which exhibited strong Cx43 staining
(Figure 6Ba–c). Following engagement by EphB2-Fc (a soluble
form of EphB2 receptor), ephrin-B1 was found in clusters
Figure 5. Eph/ephrin Interaction Inhibits Gap Junction Communication
(A) NIH 3T3 cells stably expressing ephrin-B1 were loaded with calcein-AM and dropped onto monolayers of NIH 3T3 cells either not expressing (a) or
expressing variable levels (b) and (c) of Eph-B2 receptor. Transfer of dye to neighboring cells (arrowheads) was evaluated by fluorescence after 3 h. No
dye transfer (arrows) was observed when high levels of Eph-B2 were expressed.
(B) Primary NCCs were loaded with Calcein-AM and dropped onto NIH 3T3 cells that were transfected either with a control plasmid (pcDNA3 [a]), or an
expression construct for ephrin-B1 (b) or Eph-B2 (c). In the control situation, the majority of cells transferred the dye (arrowheads). The boxed areai s
shown at higher magnification in (d). Transfer of dye is visualized by faint staining of cells surrounding the very bright donor cell. Following Eph/ephrin
interaction, many of the donor cells did not transfer the dye (arrows). Boxed areas in (b) are shown at higher magnification in (e) and (f). Cells
transferring the dye (f) and cells not transferring the dye (e) are able to spread.
(C) The percentage of cells that had spread and showed transfer of dye was evaluated after 3 hours (a). In addition, the number of receiving cells for
each donor cell was counted (b).
*p , 0.05 compared to control.
DOI: 10.1371/journal.pbio.0040315.g005
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Inhibition of GJC at ephrin Boundariesthat partially overlapped with the Cx43 punctate staining
(Figure 6Bd–f). Similar results were obtained using MDCK
cells. These results demonstrate that ephrin-B1 and Cx43
partially co-localize at the subcellular level both in absence
and presence of Eph/ephrin interaction. To test whether
ephrin-B1 and Cx43 physically interact, we performed a pull-
down assay in NIH 3T3 cells expressing ephrin-B1. We used a
recombinant protein consisting of the extracellular domain
of Eph-B2 receptor fused to the Fc fragment of human IgG
(EphB2-Fc) to pull down ephrin-B1. Cx43 was detected in the
pull down, indicating that it interacts with ephrin-B1 (Figure
6Ca). In a converse experiment, ephrin-B1 was co-immuno-
precipitated with an anti-Cx43 antibody (Figure 6Cb). These
results indicate that ephrin-B1 and Cx43 interact with each
other.
Regulation of GJC Underlies ephrin-Induced Cell Sorting
To identify the domain of ephrin-B1 required for the
interaction with Cx43, we performed a pull down using a
recombinant protein consisting of the extracellular domain
of ephrin-B1 fused to the Fc fragment of human IgG
(ephrinB1-Fc). Cx43 was not detected in the pull down
indicating that the intracellular domain of ephrin-B1 is
required for the interaction with Cx43 (Figure 6Cb). We next
asked whether the PDZ-binding domain of ephrin-B1 was
necessary for the interaction with Cx43, since Cx43 has been
shown to interact with PDZ-containing molecules, and the
data presented above suggested that Cx43 interacts with the
intracellular domain of ephrin-B1. We generated a mutant
form of ephrin-B1 that shows reduced binding to PDZ-
containing proteins (ephrin-B1
DPDZ [8]). The ability of this
mutant form of ephrin-B1 to interact with Cx43 was tested
Figure 6. Ephrin-B1 and Cx43 Co-localize and Interact with Each Other
(A) Primary mesenchymal were co-stained for Cx43 ([a], red in [c]) and ephrin-B1 ([b], green in [c]).
(B) NIH 3T3 cells were transiently transfected with ephrin-B1 and co-immunofluorescence studies were performed to detect Cx43 (a) and (d) and ephrin-
B1 (b) and (e) either without (a–c) or with engagement of ephrin-B1 (d–f). In untreated cells, Cx43 is enriched at interfaces between ephrin expressing
cells and co-localizes with ephrin-B1 (c). Engagement by EphB2-Fc results in clustering of ephrin-B1 (e) and Cx43 partially co-localizes with ephrin-B1
clusters (f). Insets present higher magnification views.
(C) Ephrin-B1 was affinity precipitated from NIH 3T3 cells using EphB2-Fc. The presence of Cx43 in the affinity complex was assessed by Western-blot (a).
Protein lysates from NIH 3T3 cells expressing ephrin-B1 were incubated with ephrinB1-Fc, and the presence of Cx43 in the affinity complexes was
assessed by Western blot (b) Cx43 was immunoprecipitated from NIH 3T3 cells expressing ephrin-B1 and the presence of ephrin-B1 in the
immunocomplexes was detected by Western blot (right panel).
IP, immunoprecipitation; Wcl, whole cell lysate.
DOI: 10.1371/journal.pbio.0040315.g006
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Inhibition of GJC at ephrin Boundariesusing NIH 3T3 cells that were transiently transfected with
either wild-type ephrin-B1 or ephrin-B1
DPDZ. Western-blot
analysis of whole cell lysates indicated that both proteins were
expressed, albeit at different levels, and that expression of
ephrin-B1 did not inﬂuence the phosphorylation status of
Cx43 (detected by differences in mobility on a SDS-PAGE),
which is known to regulate GJC (Figure 7A). Cx43 could be
detected in the pull downs from cells expressing either
ephrin-B1 wild type or ephrin-B1
DPDZ, however, the relative
abundance of phosphorylated versus unphosphorylated band
was changed. More phosphorylated Cx43 (slower mobility)
was observed in the ephrin-B1 wild-type pull down, whereas
more unphosphorylated Cx43 was detected in the ephrin-
B1
DPDZ pull down (Figure 7A). These results indicate that the
PDZ binding domain of ephrin-B1 is not required for its
interaction with Cx43; however, ephrin-B1
DPDZ and wild-type
Figure 7. Regulation of GJC Correlates with Cell Sorting
(A) NIH 3T3 cells were transiently transfected with either wild-type ephrin-B1 (B1), ephrin-B1
DPDZ (DPDZ), or a control plasmid ( ). Protein lysates were
incubated with EphB2-Fc, and the presence of Cx43 in the affinity complex was assessed by Western blot. ProtA indicates a sample that was incubated
with Protein A in absence of EphB2-Fc. Whole cell lysates (a) and affinity precipitations (b) were analyzed by Western blot.
np, non phosphorylated Cx43; p1, p2, two different forms of phosphorylated Cx43; wcl, whole cell lysate.
(B) NIH 3T3 cells were transiently transfected with ephrin-B1
DPDZ and treated with EphB2-Fc. Subcellular localization of Cx43 (a) and ephrin-B1
DPDZ (b)
was analyzed by immunofluorescence. No co-localization was observed between these two proteins (c).
(C) Paraffin sections of limb buds from E11.5 chimeric embryos obtained from injection of either ephrin-B1 null ES cells (K/O) (a) or ephrin-B1
DPDZ ES cells
(DPDZ) (b). Chimeric embryos were X-gal stained, processed for histology, and paraffin sections were counter-stained with Nuclear Fast Red. The wild-
type cells are blue whereas the mutant cells are red. Cells expressing ephrin-B1
DPDZ do not sort from wild-type cells.
(D) HEK293T cells overexpressing Cx43 were detected by immunofluorescence as a tightly packed cluster of cells (a) whereas cells expressing DsRed are
scattered among non-expressing cells (b). (c) and (d) show the visible image for the same field of cells.
DOI: 10.1371/journal.pbio.0040315.g007
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Inhibition of GJC at ephrin Boundariesephrin-B1 interact preferentially with different forms of
Cx43.
Because phosphorylated Cx43 is thought to represent
junctional Cx43 whereas unphosphorylated Cx43 represents
the inactive, cytoplasmic pool, we tested whether ephrin-
B1
DPDZ co-localized with Cx43 following engagement by
EphB2-Fc. Although ephrin-B1
DPDZ was present at the cell
surface and localized in clusters, we did not observe co-
localization of ephrin-B1
DPDZ and Cx43 following engage-
ment by EphB2-Fc (Figure 7B). To test the effect of this
mutation on calvarial development, we generated ephrin-
B1
DPDZ chimeric embryos. Examination of skeletal prepara-
tions of E18.5 ephrin-B1
DPDZ chimeras revealed that these
embryos did not exhibit defects in the calvarial bones, even in
chimeras exhibiting a high degree of contribution of mutant
ES cells (Figure S4), nor did they present polydactyly
(unpublished data). However, subtle but consistent defects
in sternum development, a phenotype that is associated with
complete loss of ephrin-B1 [7,8], were observed in almost all of
the chimeras (Figure S4), indicating that the lack of calvarial
and polydactyly phenotypes in the chimeric embryos is not
due to an ineffective contribution of ephrin-B1
DPDZ ES cells to
bone. To test the effect of the ephrin-B1
DPDZ mutation on the
distribution of Cx43 in vivo, we generated chimeric embryos
by injecting mutant ES cells carrying the ephrin-B1
DPDZ allele
(or ephrin-B1 null ES cells as a control) in wild-type ROSA 26
blastocysts. Unexpectedly, parafﬁn sections of X-gal–stained
E11.5 chimeric embryos revealed that unlike ephrin-B1 null
cells, cells expressing ephrin-B1
DPDZ do not sort-out from wild-
type cells (Figure 7C). These results indicate that mosaic loss
of reverse signaling through the PDZ binding domain is not
sufﬁcient to drive cell sorting and does not lead to defective
calvarial bone development.
The inability of ephrin-B1
DPDZ to co-localize with Cx43
upon engagement and to drive cell sorting suggested that
regulation of GJC itself may play a role in the sorting-out
process between ephrin-B1–positive and ephrin-B1–negative
cells. To test this hypothesis, we transiently transfected
HEK293T cells (that have very low levels of endogenous
Cx43) with Cx43 and allowed them to sort out following
trypsinization. Unlike control transfected cells, Cx43-over-
expressing cells segregated from untransfected cells and were
consistently found in clusters (Figure 7Da), indicating that the
establishment of GJC does indeed promote cell sorting.
Overexpression of Cx43 Partially Rescues the Calvarial
Phenotype
Because the lack of cell sorting in the experiments
described above precluded the establishment of a functional
link between the calvarial phenotype and the regulation of
GJC in ephrin-B1 heterozygote embryos, we performed a
genetic rescue experiment. Mice carrying a CMV-Cx43
transgene that allows for the generalized overexpression of
Cx43 [21] were bred to ephrin-B1
 /  mice. Western-blot
analysis showed a modest increase in the level of Cx43 in
presumptive frontal bones of embryos carrying the transgene
(unpublished data). Skeleton preparations of P1 offspring
indicated that all of the skeletal defects previously observed
in the ephrin-B1 mutants, including the phenotype speciﬁc to
ephrin-B1 heterozygotes, were also found in this mixed genetic
background (unpublished data). To assess whether over-
expression of Cx43 had an effect on the calvarial phenotype
observed in ephrin-B1
þ/  mutants, we quantiﬁed the foramen
area between the frontal bones in newborn pups from all
genotypes (see the Materials and Methods section). Although
overexpression of Cx43 had no signiﬁcant impact on the
development of the frontal bones in male pups, the foramen
area was decreased in the ephrin-B1
þ/ pups carrying the CMV-
Cx43 transgene compared to ephrin-B1
þ/  pups without the
transgene (Figure 8). Whereas the difference in foramen area
between the ephrin-B1
þ/  pups with and without the CMV-
Cx43 transgene was signiﬁcant, the degree of rescue of frontal
bone development in presence of the transgene was variable
from sample to sample (unpublished data). Importantly,
overexpression of Cx43 did not change the skeletal defects
that are independent of cell sorting (i.e., sternum defects)
(unpublished data). These results establish a functional link
between ephrin-B1 and GJC, and suggest that improper
regulation of GJC is implicated in the calvarial defects
observed in ephrin-B1 heterozygous females.
Discussion
ephrin-B1
þ/  Mice as a Model for CFNS
In this study we have shown that, analogous to humans,
heterozygous loss of ephrin-B1 in mice results in defective
development of the skull vault. Human CFNS patients
carrying mutations in the ephrin-B1 gene exhibit a range of
craniofacial defects including ocular hypertelorism, malfor-
mation of the face (in particular the forehead and the nose),
cranium biﬁdum occultum, and craniosynostosis [22]. Our
study shows that at birth, ephrin-B1
þ/  mice exhibit a delay in
the ossiﬁcation of calvarial bones leading to a frontal
foramen similar to cranium biﬁdum occultum, and in many
instances, to a biﬁd nose, mimicking the human disease.
Removing one copy of ephrin-B2 resulted in increased severity
of the frontal foramen, and an additional coronal suture
defect in an ephrin-B1
þ/  background, but had no effect in
ephrin-B1 null embryos, suggesting that the lack of phenotype
in ephrin-B1 hemizygous males is not due to functional
compensation by ephrin-B2. The effect of removing both
copies of ephrin-B2 on calvarial development could not be
analyzed due to the early embryonic lethality of ephrin-B2 null
embryos.
Interestingly, our mutant mice did not exhibit craniosyn-
ostosis of the coronal sutures seen in humans. The processes
leading to calvarial foramina and craniosynostosis are
genetically linked, as evidenced by loss of function and gain
of function mutations in the transcription factor Msx2,
respectively. Moreover, heterozygosity for the transcription
factor Twist can lead to craniosynostosis, as well as to
foramina, and both transcription factors regulate differ-
entiation of frontal bone osteoprogenitors (Ishii et al., 2003).
Ectopic bone growth observed within the coronal suture of
ephrin-B1
þ/ /ephrin-B2
þ/GFP embryos might be prescient of a
premature fusion of the suture, but this could not be analyzed
at later stages, since 100% of these animals die at birth (A.
Davy, P. Soriano, unpublished data). The genetic interaction
suggests, however, that the discrepancy in coronal suture
phenotype between ephrin-B1 heterozygous mice and humans
could be due to genetic modiﬁers. Our expression analysis
does not support a model in which wild-type expression of
ephrin-B1 controls suture formation by establishing bound-
aries in craniofacial mesenchyme. In fact, the observation
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argues that the function of ephrin-B1 is not normally required
for either calvarial bone development or proper suture
formation. On the other hand, the fact that ephrin-B1 is
expressed in the meningeal layer could account for both the
suture as well as the low-penetrance parietal bone phenotype
observed in ephrin-B1
þ/ embryos because this layer is involved
in suture and parietal bone formation [18,23].
Most of the mutations in ephrin-B1 that have been identiﬁed
in CFNS patients are located in the 59 end of the gene and are
consistent with loss-of-function mutations, either by intro-
ducing a premature stop codon, or by presumably interfering
with the binding of ephrin-B1 to Eph receptors [9,10].
However, it was reported more recently that some patients
harbored mutations in the 39 end of the gene, which might
affect speciﬁcally the reverse signaling activity of ephrin-B1
[24]. Our data using chimeric embryos demonstrate that a
mutation in the PDZ binding domain of ephrin-B1, which is
known to phenocopy some of the phenotypes observed in
ephrin-B1 null embryos including cleft palate [8], does not
induce calvarial defects or polydactyly. These results indicate
that the mutations found in CFNS patients might impinge on
protein stability, protein localization, or binding of effector
molecules independent of the PDZ domain.
Defective Osteogenic Differentiation and Inhibition of GJC
Our results are consistent with a model in which inhibition
of GJC at ectopic Eph/ephrin boundaries in ephrin-B1
þ/ 
females results in an abnormal differentiation of osteopro-
genitors, thereby leading to the defective development of
frontal bones and also, presumably, to polydactyly. Consistent
w i t hap r e v i o u sr e p o r t[ 6 ] ,w ef o u n dt h a tE p h / e p h r i n
interaction inhibits GJC. In addition, junctional Cx43 was
decreased at ectopic Eph/ephrin boundaries in vivo, and
reduced junctional Cx43 correlated with decreased osteo-
genic differentiation of primary cells isolated from ephrin-B1
heterozygous embryos. Finally, we found that overexpression
of Cx43 partially rescued the calvarial phenotype observed in
ephrin-B1 heterozygote females. These results are consistent
with other reports documenting the role of GJC and Cx43 in
osteogenic differentiation [25–27]. In addition, several genet-
ic studies have shown that defective regulation of GJC affects
craniofacial and digit development, indicating that the
structures affected in ephrin-B1 heterozygous females are
highly sensitive to alteration in GJC. Mice deﬁcient for Cx43
exhibit delayed ossiﬁcation of the calvarial bones and
craniofacial abnormalities [28], but more importantly, muta-
tions in GJA1 (the gene coding for Cx43) in humans are
responsible for oculodentodigital dysplasia (ODDD), a syn-
drome that is characterized by defective craniofacial develop-
ment and digit formation [16]. An ENU screen in mice
recently uncovered a dominant mouse mutation that exhibits
many of the classic features of ODDD, and positional cloning
revealed that these mice carry a mutation in GJA1 that acts in
a dominant-negative fashion to disrupt gap junction assembly
and function [17]. On the basis of our results, we can not rule
out the possibility that Eph/ephrin signaling might also
impinge on osteogenic differentiation directly by activating
signal transduction cascades (that would not involve the PDZ
domain of ephrin-B1). However, the cytoplasmic kinases that
are known targets of Eph/ephrin signaling (Src family kinases
and MAPKs) have been shown to be positive regulators of
osteogenic differentiation, which is not consistent with the
inhibition of differentiation that we observe in vivo and in
vitro. Moreover, we have not been able to detect a change in
the level of MAPK activation in ephrin-B1
þ/  cultures
(unpublished data).
Figure 8. Partial Rescue of the Calvarial Defect in ephrin-B1
þ/  Mice Overexpressing Cx43
Skeleton preparations from an ephrin-B1
Y/  male (a), an ephrin-B1
þ/  female (b) and an ephrin-B1
þ/  female carrying the CMV-Cx43 transgene (c).
Quantification (d) of the foramen area between the frontal bones of an ephrin-B1
þ/  female (B1
þ/ ) and an ephrin-B1
þ/  female carrying the CMV-Cx43
transgene (CMV-Cx43;B1
þ/ ). Mean values for the females with and without the transgene were normalized to the value obtained for males. The number
of embryos for each genotype is indicated. Error bars represent standard error of the mean values.
*p ¼ 0.0224.
DOI: 10.1371/journal.pbio.0040315.g008
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Inhibition of GJC at ephrin BoundariesWefoundthat ephrin-B1 and Cx43forma complex andthat
following engagement by Eph receptors, ephrin-B1 and Cx43
co-localize in clusters that could be indicative of endocytosis.
Recent reports have shown that Eph/ephrins complexes are
internalized following interaction [29–31], and endocytosis is
also a well-known mode of regulation of connexons at the cell
surface [32]. In both cases, pieces of the plasma membrane
from neighboring cells are internalized. It is therefore
conceivable that Cx43 might be co-internalized with Eph/
ephrin complexes. However, it is also possible that endocytosis
of connexons is regulated via a signal transduction cascade,
since it has been shown recently that Eph/ephrin signaling
regulates clathrin-mediated endocytosis by tyrosine phos-
phorylation of Synaptojanin 1 [33]. Tyrosine phosphorylation
of Cx43 is also a mechanism by which GJC is regulated. In our
pull-down assay, wild-type ephrin-B1 interacted preferentially
with phosphorylated Cx43 whereas ephrin-B1
DPDZ interacted
preferentially with unphosphorylated Cx43, suggesting that
the interaction between ephrin-B1 and Cx43 might not be
direct, and that these proteins might interact differently when
at the cell surface or in the cytoplasm.
Regulation of GJC and Cell Sorting
We observed that junctional Cx43 was enriched at
interfaces between ephrin-B1–positive cells, suggesting that
while GJC is inhibited at Eph/ephrin interfaces, it might be
promoted at ephrin/ephrin interfaces. This observation, as
well as the fact that overexpression of Cx43 leads to cell
sorting, supports the idea that regulation of GJC contributes
to Eph/ephrin-induced cell sorting. Although GJC has not
been formally linked to cell sorting previously, there is ample
evidence in the literature that regulation of GJC inﬂuences
cell–cell contacts. Indeed, it has been shown in various
experimental settings that inhibiting GJC, either through the
use of blocking antibodies or dominant negative constructs,
induces loss of adhesion [34–37]. In Xenopus, both over-
expression of ephrin-B1 and dominant-negative connexin
result in de-adhesion of the blastomeres [36,38]. Sorting of
cells overexpressing Cx43 has also been reported previously
in PC12 cells [39]. We therefore propose that regulation of
GJC contributes to cell sorting downstream of Eph/ephrin
interaction (Figure 9A).
A question that remains unanswered is whether or not the
cell sorting observed in ephrin-B1 heterozygotes is fully
dependent on Eph receptors. Interestingly, an Eph-indepen-
dent role for ephrin-B1 in regulating tight junctions has
recently been reported [40], and it was recently shown that
EphA4 can induce cell sorting independently of ephrins
[41,42]. However, the fact that some CFNS patients harbor
point mutations in the extracellular domain of ephrin-B1 that
presumably have an effect on Eph/ephrin interaction argues
for the involvement of Eph receptors in the sorting process.
On the basis of our data, we propose a model that explains
the dominant effect of mosaic loss of ephrin-B1 in ephrin-B1
heterozygous females, and that revisits the function of Eph/
ephrin in embryo patterning (Figure 9B). In wild-type mice
and within a developmental compartment, ephrin-expressing
cells establish GJC which stabilizes cell–cell interactions and
creates a communication compartment. In ephrin-B1 hetero-
zygotes as well as at a developmental boundary, GJC is
inhibited between ephrin-positive and Eph-positive cells,
possibly via endocytosis of Cx43, which prevents stable cell–
cell interactions and leads to the formation of distinct
compartments. Inhibition of GJC at developmental bound-
aries has been shown in a variety of models, including inter-
rhombomeric boundaries [12,43], which also happen to be
Eph/ephrin boundaries. In addition, overexpression of Cx43
has recently been shown to rescue a central nervous system
boundary defect in mice [44].
In conclusion, our work demonstrates that in addition to
their prominent role in regulating the actin cytoskeleton, Eph
receptors and ephrins also play an important role in
regulating gap junctional communication and suggests that
improper regulation of GJC leads to the phenotypes observed
in ephrin-B1 heterozygous individuals. Together, these func-
tions make Eph receptors and ephrins potent regulators of
boundary formation and tissue patterning during embryonic
development.
Materials and Methods
Mice. Ephrin-B1 mutant mice and CMV-Cx43 transgenic mice have
been described elsewhere [8,22]. The ephrin-B2
GFP allele was generated
by inserting the H2BGFP cDNA cassette at the MluI site in the ﬁrst
exon of ephrin-B2. The MluI-XbaI fragment encompassing the start
codon of the ephrin-B2 gene was replaced with H2BGFP. The
mutation was introduced in ES cells by homologous recombination.
Mice were maintained in a 129S4/C57Bl6J mixed background.
Genotyping was done by PCR using the following sets of primers:
GFP-F: 59-GCAAGAAGGCGGTGACTAAGGCGC-39;G F P - R :5 9-
GGCCGCCGCCAGTGCTTGAGGTCG-39. Mice were housed in mi-
croisolator racks in a facility accredited by the Association for the
Assessment and Accreditation of Laboratory Animal Care, and
experimentation was reviewed by the Hutchinson Center Institu-
tional Review Committee. The ES cells carrying the ephrin-B1
DPDZ
Figure 9. Mosaic Loss of ephrin-B1 and Establishment of Developmental
Boundaries
(A) Potential cross-talk between gap junctions and adherens junctions.
Ephrin-B1 co-localizes with Cx43 in junctional plaques. Co-regulation of
gap junctions and adherens junctions has been extensively studied.
(B) Establishment of communication compartments for embryo pattern-
ing. Within a compartment and in the developing calvarial bones, all cells
express ephrin-B1 and are coupled via GJC, exchanging second
messengers (black dots). At a developmental boundary and at ectopic
ephrin boundaries in ephrin-B1
þ/  embryos, Eph/ephrin interaction leads
to inhibition of GJC, possibly through endocytosis of Cx43, concomitant
with a loss of stable cell–cell interactions between the two cell types.
Sorting between these cells and inhibition of GJC concur to establish
distinct developmental compartments.
DOI: 10.1371/journal.pbio.0040315.g009
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primer speciﬁc to the mutant allele was: 59-GCCATGCTGGGCCTT
CACT-39. To obtain ephrin-B1 null ES cells, one clone of targeted ES
cells carrying the conditional allele of ephrin-B1 (ephrin-B1
lox) was
electroporated with a PGK-Cre expression vector. ES cell clones were
isolated and screened by Southern-blot for the recombined ephrin-B1
locus. Targeted ES cells were injected into blastocysts obtained from
crosses between F1 (129S4/C57Bl6J) ROSA26-bgal homozygous males
and either wild-type C57BL6J/CBAJ or MF1 females.
X-gal staining and skeletal preparations. Procedures used for X-gal
staining and skeletal preparations have been described in detail
elsewhere [8]. For the experiment with mice carrying the CMV-Cx43
transgene, quantiﬁcation of the foramen area between frontal bones
was performed using Photoshop (Adobe, San Jose, California, United
States) to record the number of pixels corresponding to the foramen.
The mean values for females with (97,901 pixels) and without (117,391
pixels) the transgene were then normalized to the mean value
obtained for males (91,824 pixels) (no signiﬁcant difference was
found between males with or without the transgene, n ¼ 10).
Statistical signiﬁcance was calculated using an unpaired t-test with
Welch correction.
In situ hybridization. Section in situ hybridization experiments
were performed on frontal sections of E14.5 embryos as described
previously [45]. Whole-mount in situ hybridization was performed
according to a protocol described elsewhere [46]. Probe sequences
used for ephrin-B1, EphB2, and EphB3 are available upon request.
Primary cultures. Presumptive frontal bone mesenchyme was
dissected from E14.5 embryos and incubated with 1% trypsin/0.5%
DNAse in PBS for 10 min at 37 8C. Trypsin was inactivated by
addition of complete medium (DMEM containing 15% FCS) and cells
were dissociated by trituration with a glass Pasteur pipette. Cells were
pelleted by centrifugation and washed twice in complete medium.
Cells were plated at high density in a 24-well plate and kept in culture
in complete medium. After 3 d, cells were ﬁxed in 2% PFA and rinsed
three times in NTMT. AP activity was detected by incubating ﬁxed
cells with NBT/BCIP (Roche, Basel, Switzerland). Some cultures were
further processed for immunoﬂuorescence as described below.
Quantiﬁcation of AP activity was performed on digital images using
the Image J software (http://rsb.info.nih.gov/ij). The data presented are
representative of ﬁve independent experiments.
Primary NCCs were isolated from dissected branchial arches of
E9.5 embryos as described above, except cells were cultured in F12
medium supplemented with 10% FCS.
GJC assays. NIH 3T3 cells were stably transfected with expression
vectors for ephrin-B1, Eph-B2 receptor, or the pcDNA3 control
vector. Recipient cells were plated at high density. Donor cells (NIH
3T3 expressing ephrin-B1 or primary NCCs) were incubated with
calcein-AM (Molecular Probes, Eugene, Oregon, United States) for 20
min at 37 8C. Calcein-AM loaded cells (donors) were extensively
washed in PBS, trypsinized, and dropped onto conﬂuent monolayers
of NIH 3T3 cells transfected with either pcDNA3 or expressing
ephrin-B1 or various levels of Eph-B2. Transfer of calcein-AM
through gap junctions was assessed after 3 h incubation at 37 8C.
GJC establishment was quantiﬁed by two means for each conditions:
(1) the percentage of cells that were spread and had transferred the
dye versus cells that were spread but did not transfer the dye; and (2)
the number of cells receiving the dye for each donor. These data were
acquired by visual assessment either directly on the inverted
microscope or from digital images. Statistical signiﬁcance was
calculated using a Student t-test.
Western blot analysis. Cells were scraped in 1% NP40 lysis buffer
(50 mM Hepes [pH 7.5], 150 mM NaCl, 10% glycerol, 1.5 mM MgCl2,
1mM EGTA, 100 mM NaF), except for the experiment presented in
Figure 7A (100 mM Tris [pH 7.4], 150 mM NaCl, 1mM EDTA). Protein
lysates were incubated with either 5-lg EphB2-Fc or 4-lg Cx43
monoclonal antibody (generous gift from P. Lampe) for 4 h at 4 8C
and subsequently with 20-ll ProteinA-Sepharose. Afﬁnity complexes
were analyzed by SDS-PAGE using the following antibodies: ephrin-
B1 (A20 or C18, Santa Cruz Biotechnology, Santa Cruz, California,
United States), Cx43 (Sigma, St. Louis, Missouri, United States). We
have noted that the binding of Cx43 to ephrin-B1 is sensitive to the
lysis buffer used: the interaction is lost in RIPA buffer.
Immunoﬂuorescence. NIH 3T3 cells were plated on glass coverslips
and transiently transfected with an expression vector for ephrin-B1.
Forty hours after transfection, cells were either ﬁxed in 2% PFA or
incubated with 4-lg/ml EphB2-Fc for 30 min at 37 8C and then ﬁxed
in PFA. Cells were permeabilized with 0.1% Tx-100 for 3 min, rinsed
in PBS, and incubated with a mix of EphB2-Fc (4 lg/ml) and either
Cx43 monoclonal antibody or N-cadherin monoclonal antibody
(Zymed, Carlsbad, California, United States). In primary cells, ephrin-
B1 was detected using the 25H11 rat monoclonal antibody [47]. FITC-
and Cy3-conjugated secondary antibodies were from Jackson
ImmunoResearch (West Grove, Pennsylvania, United States). For
the sorting experiments, HEK293T cells were transiently transfected
with either DsRed or a Cx43 expression construct. Twenty-four hours
after transfection, cells were trypsinized into a single-cell suspension
and replated onto glass coverslips. Immunoﬂuorescence was per-
formed at 48 h post-transfection using a Cx43 antibody (Sigma).
For immunoﬂuorescence on sections, parafﬁn sections were
rehydrated and subjected to a citrate boil to reveal antigens. Tissue
sections were blocked in Blocking solution (PBS/5% horse serum) 1 h
at room temperature and incubated overnight at 4 8C in Cx43
antibody (1/100 in Blocking solution [Sigma]). Incubation with the
Cy3-conjugated secondary antibody was for 1 h at room temperature
(1/250 in Blocking solution). The number of Cx43 dots was counted on
digital images acquired on a Delta Vision Deconvolution microscope
(Applied Precision Inc., Issaquah, Washington, United States). The
number of Cx43 dots was normalized to the number of junctions: for
each section, we evaluated the number of wild-type/knock-out (KO)
junctions (15–20)and counted a similarnumber of wild-type/wild-type
and KO/KO junctions on each side of the wild-type/KO boundary.
Supporting Information
Figure S1. Patterning of the Vibrissae Buds Is Altered in ephrin-B1
þ/ 
Embryos
(A) Whole E14.5 embryos were stained with H&E to highlight whiskers
buds of ephrin-B1
Y/  hemizygous males (a) and ephrin-B1
þ/  hetero-
zygous females (b). X-gal staining of E14.5 ephrin-B1
þ/lox embryo
carrying the R26R and Wnt1-Cre alleles (c). The patterning of
vibrissae buds is abnormal in heterozygote but not homozygote
mutants. This defect is autonomous to the NCC lineage since
eliminating ephrin-B1 speciﬁcally in this lineage is sufﬁcient to
phenocopy the vibrissae bud defect (c).
(B) In situ hybridization on frontal sections of E14.5 wild-type embryo
using probes for ephrin-B1 (a) and EphB2 (b) showing expression of
these genes in the mesenchyme around vibrissae buds (arrowheads).
Found at DOI: 10.1371/journal.pbio.0040315.sg001 (3.0 MB PPT).
Figure S2. Calvarial Defects and Decreased Osteogenic Differ-
entiation
(A) Skeleton preparations of whole heads from E17.5 littermate
embryos, ephrin-B2
þ/GFP single heterozygous mutants (a), ephrin-B1
þ/ 
single heterozygous females (b), and ephrin-B1
þ/ /ephrin-B2
þ/GFP
double heterozygous females (c). Ectopic bone can be seen in the
suture mesenchyme of ephrin-B1/ephrin-B2 double heterozygous
females (arrowhead in c) and the foramen between the frontal bones
is larger than in ephrin-B1
þ/  embryos. An outline of the bones is
presented for better visualization (d–f).
(B) AP staining on cryosections of E15.5 embryos. A wild-type (a), an
ephrin-B1 null male (b), and an ephrin-B1
þ/ /ephrin-B2
þ/GFP double hetero-
zygous female (c) are shown. Bone front in the control embryo (a) and
(b) is closer to the midline than bone front in the heterozygous
littermate (c). In addition, the thickness of the bone is decreased in
the ephrin-B1
þ/ /ephrin-B2
þ/GFP double heterozygous female. Both
observations show that differentiation of the frontal bone is
decreased in the heterozygote.
Found at DOI: 10.1371/journal.pbio.0040315.sg002 (2.2 MB PPT).
Figure S3. Ephrin-B1 and Cx43 Distribution in Primary Cultures and
Differentiating Frontal Bones of ephrin-B1
þ/  Embryos
(A) Ephrin-B1 was detected by immunoﬂuorescence in cultures of
primary mesenchymal cells (a) and (c) that were also stained for AP
activity (b) and (d). Expression of ephrin-B1 was readily detected as a
punctate staining on these primary cells, both in AP-positive (a) and
(b) and in AP-negative cells (c) and (d).
(B) Western blot analysis of Cx43 levels in primary cultures of
mesenchymal cells isolated from littermates of various genotypes. No
difference in the overall Cx43 levels was detected.
(C) Parafﬁn sections from E12.5 control embryos (ephrin-B1
Y/ ) (a) and
(b) and ephrin-B1
þ/ embryos (c) and (d) were stained for AP activity (a)
and (c) and subsequently processed for Cx43 immunostaining (b) and
(d). AP staining in the developing frontal bone of ephrin-B1
þ/ embryo
is more irregular than in the control embryo, consistent with the
results presented in Figure 3. However, no signiﬁcant difference can
be seen in the overall staining for Cx43 in this tissue.
Found at DOI: 10.1371/journal.pbio.0040315.sg003 (878 KB PPT).
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Inhibition of GJC at ephrin BoundariesFigure S4. ephrin-B1
DPDZ Chimeric Embryos Do Not Exhibit Calvarial
Defects
(A) Skeletal preparations of whole heads from E18.5 ephrin-B1
DPDZ
chimeric embryos showing low (a) and high (b) contribution of
mutant ES cells, assessed by PCR on tail DNA (c).
(B)SkeletalpreparationsofE18.5wild-type(a),ephrin-B1
 / (b),andephrin-
B1
DPDZ chimeras (c) and (d) show that chimeric embryos exhibit sternum
defects reminiscent of ephrin-B1 null embryos.
Found at DOI: 10.1371/journal.pbio.0040315.sg004 (1.1 MB PPT).
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